Search Results
Drug Development: Mogamulizumab
Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
Drug Development: Brentuximab Vedotin
Mogamulizumab-associated rash and its implications in CTCL care, N.A. Trum et al
Facebook Live: Mogamulizumab - Pierluigi Porcu, MD
MAVORIC: long-term clinical benefit of mogamulizumab in patients with CTCL
Mogamulizumab: an exciting antibody for autoimmunity
Mogamulizumab for patients with CTCL
How POTELIGEO Uniquely Targets CCR4
Facebook Live: ASH Update/Brentuximab - Pierluigi Porcu, MD
Methods to access the clinical efficacy of mogamulizumab
Mogamulizumab-associated rash in patients with CTCL
